✦ LIBER ✦

Alefacept Is Well Tolerated in Patients with Chronic Plaque Psoriasis

✍ Scribed by Alice B. Gottlieb

Book ID: 106298226
Publisher: Springer-Verlag
Year: 2004
Tongue: English
Weight: 114 KB
Volume: 8
Category: Article
ISSN: 1203-4754
DOI: 10.1007/s10227-004-9504-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Repeat courses of intravenous alefacept

Repeat courses of intravenous alefacept in patients with chronic plaque psoriasis provide consistent safety and efficacy

✍ Nick J. Lowe; John Gonzalez; Jerry Bagel; Ivor Caro; Charles N. Ellis; Alan Ment 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB

## Abstract **Background** Psoriasis is a chronic, relapsing skin disease that may require multiple treatment courses. Alefacept targets the memory T cells implicated in psoriasis pathogenesis. This open‐label study evaluated the safety and tolerability, efficacy, and pharmacodynamics of repeat cou

Vitamin D status in patients with chroni

Vitamin D status in patients with chronic plaque psoriasis

✍ P. Gisondi; M. Rossini; A. Di Cesare; L. Idolazzi; S. Farina; G. Beltrami; K. Pe 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB

Improved health-related quality of life

Improved health-related quality of life following a randomized controlled trial of alefacept treatment in patients with chronic plaque psoriasis

✍ S.R. Feldman; A. Menter; J.Y. Koo 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Plasma homocysteine and folate levels in

Plasma homocysteine and folate levels in patients with chronic plaque psoriasis

✍ M. Malerba; P. Gisondi; A. Radaeli; R. Sala; P.G. Calzavara Pinton; G. Girolomon 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB

Disseminated molluscum contagiosum in a

Disseminated molluscum contagiosum in a patient with chronic plaque psoriasis taking methotrexate

✍ K.S. Lim; C. C. I. Foo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 997 KB

Once weekly administration of etanercept

Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension

✍ P.C.M. Van De Kerkhof; S. Segaert; M. Lahfa; T.A. Luger; Z. Karolyi; A. Kaszuba; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB